Sort
48,018 grants matching “immunotherapy”
Investigating T Cell Egress via Lymphatic Vessels in Melanoma
$379,977Amanda W. Lund · New York University School Of Medicine · R01 · FY2023 · CA
Potentiating Checkpoint Blockade by Cross-Priming Tumor-Reactive T cells with In Situ Vaccination
$379,977Joshua D Brody · Icahn School Of Medicine At Mount Sinai · R37 · FY2023 · CA
Informatics for Functional Integration of Heterogeneous Cancer Genome and Transcriptome Sequencing Data
$379,972Ken Chen · University Of Tx Md Anderson Can Ctr · U01 · FY2022 · CA
New Strategies for Treatment of NRAS Mutant Melanoma after Progression on Immune Checkpoint Inhibitors
$379,970Ann Richmond · Vanderbilt University · R01 · FY2021 · CA
Mechanisms of Viral Persistence
$379,965David G. Brooks · University Of California Los Angeles · R01 · FY2010 · AI
Machine Learning-Assisted Integrated Optofluidic Nanoplasmonic Biosensing for Precision Immune Profiling and Monitoring
$379,956Pengyu Chen · Auburn University At Auburn · R35 · FY2024 · GM
Four-dimensional Adhesion Frequency Assay for Full Profiling of Receptor-ligand Interactions on Cells
$379,953Yuebing Zheng · University Of Texas At Austin · R01 · FY2023 · GM
Four-dimensional Adhesion Frequency Assay for Full Profiling of Receptor-ligand Interactions on Cells
$379,952Yuebing Zheng · University Of Texas At Austin · R01 · FY2022 · GM
Artif. Antigen Presentation to Sensitize Virus-Spec. TCells for Adoptive Immunoth
$379,945Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2010 · CA
Genetics and Immune Predictors for Recurrent Glomerular Diseases in the Kidney Allograft
$379,945Ibrahim Batal · Columbia University Health Sciences · R01 · FY2023 · DK
Modulation of chronic vascular inflammation by iNKT cells
$379,913Luc Van Kaer · Vanderbilt University · R01 · FY2012 · HL
EASTERN COOPERATIVE ONCOLOGY GROUP STUDIES
$379,895Case Western Reserve University · U10 · FY2002 · CA
Endogenous TLR1 signals prevent uncontrolled innate immunity in the colon
$379,875Randy William Depaolo · University Of Washington · R01 · FY2019 · DK
IL12 AS AN IMMUNOPOTENTIATOR IN LEISHMANIASIS
$379,801University Of Pennsylvania · R01 · FY2001 · AI
Project 2
$379,776David A Barbie · Dana-Farber Cancer Inst · P50 · FY2023 · CA
Antigenic Determinants on HLA-B7 and -A2
$379,773Victor H. Engelhard · University Of Virginia · R01 · FY2008 · CA
Breaking Tolerance to Induce Tumor-Specific Cytotoxic CD4 Th1 Cells
$379,747Adam J Adler · University Of Connecticut Sch Of Med/Dnt · R01 · FY2012 · AI
NEUTRALIZING ANTIBODIES AGAINST ORTHOPOX VIRUSES
$379,746Scripps Research Institute · U01 · FY2004 · AI
Research Training in Immunology
$379,738David H Sherr · Boston University Medical Campus · T32 · FY2010 · AI
Credentialing a Genetically Engineered Clinically-Relevant Mouse Model of Multiple Myeloma
$379,725Marta Chesi · Mayo Clinic Arizona · R01 · FY2019 · CA
Credentialing a Genetically Engineered Clinically-Relevant Mouse Model of Multiple Myeloma
$379,725Marta Chesi · Mayo Clinic Arizona · R01 · FY2020 · CA
Credentialing a Genetically Engineered Clinically-Relevant Mouse Model of Multiple Myeloma
$379,725Marta Chesi · Mayo Clinic Arizona · R01 · FY2021 · CA
Delineating how nucleic acid sensing in tumorcells regulate anti-tumor immune responses
$379,690Malay Haldar · University Of Pennsylvania · P01 · FY2025 · CA
Inhibitory Pathways Underlying Viral Persistance in vivo
$379,684Elina I Zuniga · University Of California, San Diego · R01 · FY2009 · AI
IDO2 Targeting in Pancreatic Cancer
$379,675George C Prendergast · Lankenau Institute For Medical Research · R01 · FY2019 · CA